Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD19-chimeric Antigen Receptor T Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07097207
What this trial is testing

Efficacy and Safety of CD19CD20-CAR.p40-T in B-cell Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Lymphoma
Shenzhen University General Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06735495
What this trial is testing

CD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors

Who this might be right for
B-Cell Lymphoblastic Leukemia/Lymphoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07020260
What this trial is testing

The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies

Who this might be right for
LeukemiaLymphoma
Princess Maxima Center for Pediatric Oncology 18
Testing effectiveness (Phase 2)Study completedNCT03173417
What this trial is testing

Safety and Efficacy Evaluation of IM19 CAR-T Cells (IM19CAR-T)

Who this might be right for
Leukemia
Beijing Immunochina Medical Science & Technology Co., Ltd. 177
Early research (Phase 1)Active Not RecruitingNCT03186118
What this trial is testing

Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia

Who this might be right for
CD 19+ Acute Leukemia
Seattle Children's Hospital 30
Early research (Phase 1)WithdrawnNCT05168748
What this trial is testing

CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals
Not applicableWithdrawnNCT06508346
What this trial is testing

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV

Who this might be right for
ANCA Associated VasculitisCAR-T Cell Therapy
The Children's Hospital of Zhejiang University School of Medicine
Early research (Phase 1)Looking for participantsNCT07224373
What this trial is testing

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
AstraZeneca 24
Testing effectiveness (Phase 2)Looking for participantsNCT06014073
What this trial is testing

TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL

Who this might be right for
Non Hodgkin's Lymphoma
Chinese PLA General Hospital 30
Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Testing effectiveness (Phase 2)Looking for participantsNCT04836507
What this trial is testing

Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients

Who this might be right for
Relapsed Large B-cell LymphomaRefractory Large B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)+4 more
Curocell Inc. 91
Very early researchLooking for participantsNCT06920433
What this trial is testing

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Zhejiang University 18
Early research (Phase 1)UnknownNCT03281551
What this trial is testing

Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Lymphoma
Pinze Lifetechnology Co. Ltd. 50
Testing effectiveness (Phase 2)UnknownNCT05755828
What this trial is testing

Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
The Affiliated Hospital of Xuzhou Medical University 30
Not applicableLooking for participantsNCT07120633
What this trial is testing

Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL

Who this might be right for
CLLCAR-T Cell TherapySLL
The Affiliated Hospital of Xuzhou Medical University 50
Testing effectiveness (Phase 2)Ended earlyNCT03287817
What this trial is testing

Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma

Who this might be right for
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Autolus Limited 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05436496
What this trial is testing

CD19/70 Bi-specific CAR-T Cell Therapy

Who this might be right for
B Cell Malignancies
Shenzhen Geno-Immune Medical Institute 30
Very early researchLooking for participantsNCT07337785
What this trial is testing

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

Who this might be right for
Relapsing or Refractory Multiple Sclerosis (MS)Myasthenia Gravis (MG)Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)+1 more
Tongji Hospital 36
Early research (Phase 1)Looking for participantsNCT07266181
What this trial is testing

Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy

Who this might be right for
Refractory Membranous Nephropathy
The First Affiliated Hospital of Air Force Medicial University 5
Not applicableUnknownNCT05269914
What this trial is testing

Safety, Efficacy and Pharmacokinetics of XKDCT023 in DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
The Affiliated Hospital of Qingdao University 10
Next Page